Hot Investor Mandate: Taiwan-Based Evergreen Fund Invests in Novel Therapeutics, Medical Devices, and Digital Health Companies Across the Globe

27 Jan

A firm based in Taiwan invests from an evergreen fund, and is a multi-stage investor, with investments made from seed stage all the way to IPO. The firm invests both in Taiwan and internationally, including in the US and Canada.  Investments are typically of $500,000-2 million.

The firm invests in a variety of sectors including medical devices, therapeutics, and digital health/AI.  The firm prefers to invest in companies with a pipeline of multiple assets rather than in single asset companies.  For therapeutics, the firm looks internationally for novel assets: within Taiwan, the firm focuses on repurposed drugs.

The firm prefers to invest in companies that already have a complete team.  For medical device companies, this must include commercial/sales staff.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: